Up to 80% of people with asthma also experience allergic rhinitis. When left untreated, nasal allergy symptoms can have a significant impact on asthma control, increasing the risk of flare-ups and affecting day-to-day quality of life.

In this expert-led session, we explore the “one airway” concept — highlighting the close connection between the nose and lungs — and why effective management of both conditions is so important.

The webinar covers common seasonal and perennial allergens, including pollen, dust mites, mould and pet dander, as well as the growing impact of longer and more intense pollen seasons.

You’ll also learn how allergic rhinitis is diagnosed, including the role of allergy testing in confirming triggers, and the range of treatment options available. These include antihistamines, intranasal corticosteroids, eye treatments, and in some cases, sublingual immunotherapy.

Importantly, the session provides practical advice on managing both asthma and allergic rhinitis together — including allergen avoidance strategies, treatment adherence, and taking a whole-airway approach to care.

Watch the recording now to gain practical, expert guidance to help improve asthma control and manage symptoms throughout the year.

This webinar was kindly supported by ALK and A.Menarini.

On Wednesday 25 March 2026, from 7–8pm, we will host a free webinar exploring the “one airway” concept and explaining how allergens such as pollen, dust mites, mould and pet dander can affect both the nose and lungs. With pollen seasons becoming longer and more intense, understanding your triggers and treatment options is increasingly important.

Speakers

Alternative nebule products are available and can be reimbursed under existing community drug schemes.

If you are having difficulty accessing your prescribed nebules, please speak to your pharmacist.

While these shortages last, temporary arrangements are in place:

• If you have a Medical Card, your pharmacist can apply for reimbursement under the Discretionary Hardship Arrangements.
• If you are registered for the Drugs Payment Scheme (DPS), alternative products are supported under that.
• If you are not currently registered for a Medical Card or the DPS and think you may be eligible, your pharmacist or GP can advise you on how to apply.

As participation in certain reimbursement arrangements may vary between community pharmacies and local health regions, patients are encouraged to speak with their pharmacist, who can advise on the most appropriate options available locally.

Nebulised salbutamol remains an important treatment in severe or life-threatening asthma attacks. However, it is important to remember that, when used correctly, ten puffs of a blue reliever inhaler delivered one puff at a time through a spacer can provide a similar effect to a standard nebuliser dose.

Nebulisers should only be used at home under medical guidance, as inappropriate use may mask worsening symptoms and delay access to emergency care.

The Asthma Society encourages all people with asthma and their caregivers to be confident in using a spacer device correctly. Done properly, this technique is highly effective and can save lives.

Please find a video demonstrating this technique here.